[Current therapy concepts in allergic and hyperergic diseases of the upper airways].
Rudack
C
C
HNO-Klinik, Universitäts-Klinikum Münster, Kardinal-von-Galen-Ring 10, 48149 Münster. rudack@uni-muenster.de
D000485:Allergens; D001905:Botulinum Toxins / Q000008:administration & dosage / Q000627:therapeutic use; D002211:Capsaicin / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D018680:Cholinergic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D003888:Desensitization, Immunologic; D004391:Dust; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006633:Histamine Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007073:Immunoglobulin E / Q000096:biosynthesis; D014663:Nasal Decongestants / Q000627:therapeutic use; D012220:Rhinitis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D012221:Rhinitis, Allergic, Perennial / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D013997:Time Factors
D000485:Allergens; D018680:Cholinergic Antagonists; D004391:Dust; D005938:Glucocorticoids; D006633:Histamine Antagonists; D014663:Nasal Decongestants; D007073:Immunoglobulin E; D001905:Botulinum Toxins; D002211:Capsaicin